查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1601612

全基因組定序市場規模、佔有率、預測和趨勢分析：按提供（文庫製備、DNA提取）、按測序類型（大規模、小規模、分階段）、按技術（SBS、SMRT、Nanopore、Nanoball），按應用、按最終用戶– 到2031 年的全球預測

Whole Genome Sequencing Market Size, Share, Forecast, & Trends Analysis by Offering (Library Preparation, DNA Extraction) Sequencing Type (Large, Small, Phased), Technology (SBS, SMRT, Nanopore, Nanoball) Application, End User - Global Forecast to 2031
出版日期: | 出版商: Meticulous Research | 英文 312 Pages | 商品交期: 最快1-2個工作天內

價格

預計到 2031 年，全球全基因組定序市場將達到 71.7 億美元，2024 年至 2031 年複合年增長率為 15.2%。

經過廣泛的二次和初步研究以及對市場情景的詳細分析，本報告對關鍵行業推動因素、阻礙因素、挑戰和機會進行了分析。定序成本的下降、癌症和遺傳患者病率的增加、全基因組測序在疾病診斷和精準醫學中的使用增加、藥品研發費用的增加以及全基因組測序在監管和報銷方面的改進推動了肺活量計市場的成長。然而，全基因組定序耗材的高成本、識別精準醫學積極可行變異的可能性較低，以及與全基因組定序診斷相關的倫理和法律問題正在限制該市場的成長。

此外，全基因組定序應用的增加、政府對大規模基因組定序計畫的支持以及新興國家預計將為該市場的參與者提供成長機會。然而，監管環境的不確定性、中小型實驗室的專業知識和測序能力有限、新興國家缺乏測序專家以及NGS設置所需的高資本投資已成為市場成長的重大挑戰。

本報告是基於對 Masu 四年期間（2021-2024 年）產品組合供應、區域發展和關鍵策略發展的廣泛評估，提供了競爭格局。全球全基因組定序市場的主要公司有 Illumina, Inc.（美國）、Thermo Fisher Scientific, Inc.（美國）、QIAGEN N.V.（荷蘭）、F. Hoffmann-La Roche Ltd.（瑞士）、PerkinElmer , Inc.（美國）、Agilent Technologies, Inc.（美國）、Pacific Biosciences of California Inc.（美國）、Danaher Corporation（美國）、Bio-Rad Laboratories, Inc.（美國）、Oxford Nanopore Technologies Plc.（英國）、華大智造科技有限公司（中國）和北京華大基因研究院（BGI）（中國）。

在本報告研究的所有產品中，耗材領域預計將佔據全基因組定序市場的最大佔有率，超過 70.1%。此細分市場的龐大市佔率可歸因於消耗品的重複使用、試劑和目標富集方案及相關消耗品的持續進步，以及全基因組定序在臨床環境中的應用不斷增加。

在本報告研究的所有定序類型中，全基因組定序部分預計將在 2024 年佔據全基因組定序市場的最大佔有率。此細分市場擁有很大的市場佔有率，因為大規模全基因組定序提供了基因組的高解析度和逐鹼基視圖，並可用於對大型基因組進行定序以提供群體層級的研究。

在本報告研究的所有技術中，預計到 2024 年，合成定序部分將佔據全基因組定序市場的最大佔有率。該領域的巨大市場佔有率歸因於合成測序技術的廣泛採用，這些技術提供了高精度，支援雙端和單紅色文庫，並使得高解析度基因組測序成為可能。

在本報告調查的所有應用中，研究應用預計將在 2024 年佔據全基因組定序市場的最大佔有率。該細分市場的巨大市場佔有率歸因於越來越多地使用全基因組測序來識別新的藥物標靶、對基於基因的藥物的需求不斷增加以及對藥物研發活動的需求不斷增長。

在本報告研究的所有最終用戶中，製藥和生技公司領域預計將在 2024 年佔據全基因組定序市場的最大佔有率。據認為，該領域的巨大市場佔有率是由於製藥和生物技術公司研發支出的增加以及遺傳疾病盛行率的上升，這刺激了全基因組測序在這些行業的採用。

對全球全基因組定序市場區域狀況的詳細分析提供了五個主要區域（北美、歐洲、亞太地區、拉丁美洲、中東和非洲）的詳細定性和定量見解，每個區域涵蓋了地區主要國家。預計到 2024 年，北美將佔據全基因組定序市場的最大佔有率，超過 52.1%。在同一地區，2024年美國預計將佔據北美全基因組定序市場的最大佔有率。北美的巨大市場佔有率是由全基因組測序的高度認知、支持基因組研究的有利政府舉措、基於NGS的研究應用的增加、測序成本的下降、癌症的高患病率以及由於不同的贖回場景等因素而提供的支持所推動的。

調查範圍：

全基因組定序市場評估：透過產品

  • 消耗品
    • 樣品製備試劑盒/試劑
  • 核酸萃取/擴增
  • 文庫準備/目標富集
  • 品質控制
  • 其他消耗品
  • 設備
  • 軟體
  • 服務

註：其他耗材包括小瓶、移液管、容器、托盤、定序試劑、流通池、管路等。

全基因組定序市場評估：依序列類型

  • 大規模全基因組定序
  • 小規模全基因組定序
  • 人類全基因組定序
  • 其他全基因組定序類型

注意：其他全基因組定序類型包括從頭定序、分階段定序、長讀長定序和逐次克隆定序。

全基因組定序市場評估：依技術

  • 依成分排列的順序
  • 離子半導體序列
  • DNA 奈米球序列
  • 單分子即時定序
  • 其他 NGS 技術

註：其他全基因組定序技術包括奈米孔定序、AVITI 定序（Avidity 基礎化學 (ABC)）。

全基因組定序市場評估：依應用劃分

  • 研究和其他用途
    • 藥物發現
    • 農業/動物研究
    • 其他用途
  • 臨床應用
    • 生殖醫學
    • 腫瘤學
    • 傳染病
    • 其他臨床用途

註：其他應用包括食品微生物學、飲料產業微生物組分析、環境研究等。

其他臨床應用包括檢測神經系統疾病、罕見疾病、代謝和免疫疾病以及食源性疾病的遺傳異常。

全基因組定序市場評估<：依最終使用者/p>

  • 製藥和生技公司
  • 醫院/診斷實驗室
  • 學術機構/研究中心
  • 其他最終用戶

註：其他最終使用者主要包括法醫實驗室和安全機構、食品和飲料公司以及農業公司。

全基因組定序市場評估：按地區

  • 北美
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 義大利
  • 西班牙
  • 其他歐洲 (RoE)
  • 亞太地區
  • 日本
  • 中國
  • 印度
  • 澳大利亞
  • 韓國
  • 其他亞太地區 (RoAPAC)
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他拉丁美洲 (RoLATM)
  • 中東/非洲

目錄

第1章簡介

第2章研究方法

第 3 章執行摘要

第 4 章市場洞察

  • 摘要
  • 影響市場成長的因素
    • 市場動態影響分析
    • 因素分析
  • 價格分析
  • 技術趨勢
    • 新興定序公司專注於改進技術和降低成本
      • Singular Genomics Systems, Inc.（美國）
      • Ultima Genomics, Inc.（美國）
      • Element Biosciences（美國）
    • 主要市場參與者對便攜式即時定序技術的重視
  • 監理分析
    • 北美
      • 美國
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東
  • 波特五力分析

第 5 章全基因組定序市場評估：透過產品

  • 摘要
  • 消耗品
    • 樣品製備消耗品
      • 用於文庫製備和目標富集的耗材
      • 核酸萃取與擴增耗材
      • 品質管制消耗品
      • 其他試劑盒/試劑
    • 其他消耗品
  • 設備
  • 軟體
  • 服務

第 6 章全基因體定序市場評估：依序列類型

  • 摘要
  • 大規模全基因組定序
  • 小規模全基因組定序
  • 分階段序列
  • 其他全基因組定序類型

第7章全基因體定序市場評估：依應用

  • 摘要
  • 研究和其他用途
    • 藥物發現
    • 農業/動物研究
    • 其他用途
  • 臨床應用
    • 腫瘤學
    • 生殖醫學
    • 傳染病
    • 其他臨床用途

第 8 章全基因體定序市場評估：依技術

  • 摘要
  • 邊合成邊定序 (SBS)
  • 離子半導體序列
  • 單分子即時定序
  • DNA 奈米球序列
  • 其他全基因組定序技術

第 9 章全基因體定序市場評估：依最終使用者

  • 摘要
  • 製藥和生技公司
  • 醫院/診斷實驗室
  • 學術/研究機構
  • 其他最終用戶

第 10 章全基因體定序市場評估：按地區

  • 摘要
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他拉丁美洲地區
  • 中東/非洲

第11章競爭分析

  • 摘要
  • 主要成長策略
  • 競爭基準測試
  • 競爭對手儀表板
    • 行業領導者
    • 市場差異化因素
    • 領先企業
    • 新興公司
  • 市佔率分析（2023 年）
    • Illumina, Inc.（U.S.）
    • Thermo Fisher Scientific Inc.（U.S.）
    • MGI Tech Co., Ltd.（China）

第12章公司簡介（業務概覽、財務概覽、產品組合、策略發展、SWOT 分析*）

  • Illumina, Inc.（U.S.）
  • Thermo Fisher Scientific Inc.
  • F. Hoffmann-La Roche Ltd
  • QIAGEN N.V.
  • Agilent Technologies, Inc.
  • Revvity, Inc.
  • Pacific Biosciences of California Inc.
  • Danaher Corporation
  • Oxford Nanopore Technologies Plc.
  • MGI Tech Co., Ltd.

（註：提供上位5公司的SWOT分析）

第13章 附錄

Product Code: MRHC - 1041386

The global whole genome sequencing market is projected to reach $7.17 billion by 2031 at a CAGR of 15.2% from 2024 to 2031.

Succeeding extensive secondary and primary research and in-depth analysis of the market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the spirometers market is driven by the declining costs of sequencing, the increasing prevalence of cancer & genetic disorders, the growing utilization of whole genome sequencing in disease diagnostics & precision medicine, increasing pharmaceutical R&D expenditures, improvements in regulatory & reimbursement scenarios for whole genome sequencing, rising healthcare expenditures, increasing funding for research activities, the growing need for the early detection & prevention of diseases, technological advancements in sequencing products, and government initiatives promoting the use of sequencing in clinical & research applications. However, the high costs of whole genome sequencing consumables, the low chances of identifying positive, actionable mutations for precision medicine, and the ethical & legal issues related to whole genome sequencing-based diagnosis restrain the growth of this market.

Furthermore, increasing applications of whole genome sequencing, government support for large-scale genomic sequencing projects, and emerging economies are expected to generate growth opportunities for the players operating in this market. However, the uncertainties in the regulatory landscape, the limited expertise & sequencing capabilities of small & medium-sized laboratories, the lack of sequencing professionals in developing countries, and the high capital investments required for NGS setups pose a major challenge to market growth.

The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2021-2024). The key players operating in the global whole genome sequencing market are Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S), QIAGEN N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), PerkinElmer, Inc. (U.S) Agilent Technologies, Inc. (U.S), Pacific Biosciences of California Inc. (U.S), Danaher Corporation (U.S), Bio-Rad Laboratories, Inc. (U.S.), Oxford Nanopore Technologies Plc. (U.K),MGI Tech Co., Ltd. (China), Beijing Genomics Institute (BGI) (China).

Among all the offerings studied in this report, the consumables segment is expected to account for the largest share of over 70.1% of the whole genome sequencing market. This segment's large market share can be attributed to the recurring use of consumables, continuous advancements in reagents and target enrichment protocols and associated consumables, and the increasing applications of whole genome sequencing in clinical settings.

Among all the sequencing types studied in this report, in 2024, the whole genome sequencing segment is expected to account for the largest share of the whole genome sequencing market. This segment's large market share can be attributed to the large whole genome sequencing provides high resolution and base-by-base view of the genome and helps in sequencing large genome for providing population-level studies.

Among all the technologies studied in this report, in 2024, the sequencing by synthesis segment is expected to account for the largest share of the whole genome sequencing market. This segment's large market share can be attributed to the widespread adoption of sequencing by synthesis technology, which offers high accuracy and supports both paired-end and single-read libraries, enabling high-resolution genome sequencing.

Among all the applications studied in this report, in 2024, the research applications segment is expected to account for the largest share of the whole genome sequencing market. This segment's large market share is attributed to the increasing use of whole genome sequencing to identify novel drug targets, the rising demand for gene-based medicines, and growing investments in drug research and development activities.

Among all the end users studied in this report, in 2024, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the whole genome sequencing market. This segment's large market share can be attributed to increased R&D spending by pharmaceutical and biotechnology firms, along with the rising incidence of genetic diseases, which is fueling the adoption of whole genome sequencing in these industries.

An in-depth analysis of the geographical scenario of the global whole genome sequencing market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2024, North America is expected to account for the largest share of over 52.1% of the whole genome sequencing market. In the region in 2024, the U.S. is expected to account for the largest share of the whole genome sequencing market in North America. North America's significant market share can be attributed to factors such as high awareness of whole genome sequencing, favorable government initiatives supporting genomics research, increasing applications of NGS-based research, decreasing sequencing costs, a high prevalence of cancer, and a supportive reimbursement scenario.

Scope of the Report:

Whole Genome Sequencing Market Assessment- by Offering

  • Consumables
    • Sample Preparation Kits & Reagents
  • Nucleic Acid Extraction & Amplification
  • Library Preparation & Target Enrichment
  • Quality Control
  • Other Consumables
  • Instruments
  • Software
  • Services

Note: Other consumables include vials, pipettes, containers, trays, sequencing reagents, flow cells, and tubes.

Whole Genome Sequencing Market Assessment- by Sequencing Type

  • Large Whole-Genome Sequencing
  • Small Whole-Genome Sequencing
  • Human Whole-Genome Sequencing
  • Other Whole-Genome Sequencing Types

Note: Other Whole-genome sequencing types include De novo sequencing, Phased sequencing, Long-read sequencing, and Clone-by-clone sequencing.

Whole Genome Sequencing Market Assessment- by Technology

  • Sequencing by Synthesis
  • Ion Semiconductor Sequencing
  • DNA Nanoball Sequencing
  • Single-molecule Real-time Sequencing
  • Other NGS Technologies

Note: Other whole genome sequencing technologies include nanopore sequencing and AVITI sequencing (Avidity base chemistry (ABC).

Whole Genome Sequencing Market Assessment-by Application

  • Research and Other Applications
    • Drug Discovery
    • Agriculture and Animal Research
    • Other Applications
  • Clinical Applications
    • Reproductive Health
    • Oncology
    • Infectious Diseases
    • Other Clinical Applications

Note: Other applications include food microbiology, microbiota analysis in the beverage industry, and environmental studies.

Other clinical applications include the detection of genetic aberrations in neurological disorders, rare diseases, metabolic and immune disorders, and food-borne illnesses.

Whole Genome Sequencing Market Assessment-by End User

  • Pharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Academic Institutes & Research Centers
  • Other End Users

Note: Other end users primarily include forensic laboratories & security agencies, food & beverage companies, and agriculture companies.

Whole Genome Sequencing Market Assessment-by Geography

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K
  • Italy
  • Spain
  • Rest of Europe (RoE)
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific (RoAPAC)
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America (RoLATM)
  • Middle East & Africa

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Ecosystem
  • 1.3. Currency And Limitations
  • 1.4. Key Stakeholders

2. Research Methodology

  • 2.1. Research Process
  • 2.2. Process of Data Collection and Validation
    • 2.2.1. Secondary Research
    • 2.2.2. Primary Research
  • 2.3. Market Sizing and Forecast
    • 2.3.1. Market Size Estimation Approach
    • 2.3.2. Market Share Analysis
    • 2.3.3. Growth Forecast Approach
  • 2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights

  • 4.1. Overview
  • 4.2. Factors Affecting Market Growth
    • 4.2.1. Impact Analysis of Market Dynamics
    • 4.2.2. Factor Analysis
  • 4.3. Pricing Analysis
  • 4.4. Technology Trends
    • 4.4.1. Emerging Sequencing Companies' Focus on Improving Technologies and Reducing Costs
      • 4.4.1.1. Singular Genomics Systems, Inc. (U.S.)
      • 4.4.1.2. Ultima Genomics, Inc. (U.S.)
      • 4.4.1.3. Element Biosciences (U.S.)
    • 4.4.2. Key Market Players' Emphasis on Portable and Real-Time Sequencing Technologies
  • 4.5. Regulatory Analysis
    • 4.5.1. North America
      • 4.5.1.1. U.S.
    • 4.5.2. Europe
    • 4.5.3. Asia-Pacific
    • 4.5.4. Latin America
    • 4.5.5. Middle East
  • 4.6. Porter's Five Forces Analysis

5. Whole Genome Sequencing Market Assessment-by Offering

  • 5.1. Overview
  • 5.2. Consumables
    • 5.2.1. Sample Preparation Consumables
      • 5.2.1.1. Library Preparation & Target Enrichment Consumables
      • 5.2.1.2. Nucleic Acid Extraction & Amplification Consumables
      • 5.2.1.3. Quality Control Consumables
      • 5.2.1.4. Other Kits & Reagents
    • 5.2.2. Other Consumables
  • 5.3. Instruments
  • 5.4. Software
  • 5.5. Services

6. Whole Genome Sequencing Market Assessment-by Sequencing Type

  • 6.1. Overview
  • 6.2. Large Whole-Genome Sequencing
  • 6.3. Small Whole-Genome Sequencing
  • 6.4. Phased Sequencing
  • 6.5. Other Whole-Genome Sequencing Types

7. Whole Genome Sequencing Market Assessment-by Application

  • 7.1. Overview
  • 7.2. Research & Other Applications
    • 7.2.1. Drug Discovery
    • 7.2.2. Agricultural & Animal Research
    • 7.2.3. Other Applications
  • 7.3. Clinical Applications
    • 7.3.1. Oncology
    • 7.3.2. Reproductive Health
    • 7.3.3. Infectious Diseases
    • 7.3.4. Other Clinical Applications

8. Whole Genome Sequencing Market Assessment-by Technology

  • 8.1. Overview
  • 8.2. Sequencing by Synthesis (SBS)
  • 8.3. Ion Semiconductor Sequencing
  • 8.4. Single-Molecule Real-Time Sequencing
  • 8.5. DNA Nanoball Sequencing
  • 8.6. Other Whole Genome Sequencing Technologies

9. Whole Genome Sequencing Market Assessment-by End User

  • 9.1. Overview
  • 9.2. Pharmaceutical & Biotechnology Companies
  • 9.3. Hospitals & Diagnostic Laboratories
  • 9.4. Academic & Research Institutes
  • 9.5. Other End Users

10. Whole Genome Sequencing Market Assessment-by Geography

  • 10.1. Overview
  • 10.2. North America
    • 10.2.1. U.S.
    • 10.2.2. Canada
  • 10.3. Europe
    • 10.3.1. Germany
    • 10.3.2. France
    • 10.3.3. U.K.
    • 10.3.4. Italy
    • 10.3.5. Spain
    • 10.3.6. Rest of Europe
  • 10.4. Asia-Pacific
    • 10.4.1. China
    • 10.4.2. Japan
    • 10.4.3. India
    • 10.4.4. Rest of Asia-Pacific
  • 10.5. Latin America
    • 10.5.1. Brazil
    • 10.5.2. Mexico
    • 10.5.3. Rest of Latin America
  • 10.6. Middle East & Africa

11. Competition Analysis

  • 11.1. Overview
  • 11.2. Key Growth Strategies
  • 11.3. Competitive Benchmarking
  • 11.4. Competitive Dashboard
    • 11.4.1. Industry Leaders
    • 11.4.2. Market Differentiators
    • 11.4.3. Vanguards
    • 11.4.4. Emerging Companies
  • 11.5. Market Share Analysis (2023)
    • 11.5.1. Illumina, Inc. (U.S.)
    • 11.5.2. Thermo Fisher Scientific Inc. (U.S.)
    • 11.5.3. MGI Tech Co., Ltd. (China)

12. Company Profiles (Business Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)

  • 12.1. Illumina, Inc. (U.S.)
  • 12.2. Thermo Fisher Scientific Inc.
  • 12.3. F. Hoffmann-La Roche Ltd
  • 12.4. QIAGEN N.V.
  • 12.5. Agilent Technologies, Inc.
  • 12.6. Revvity, Inc.
  • 12.7. Pacific Biosciences of California Inc.
  • 12.8. Danaher Corporation
  • 12.9. Oxford Nanopore Technologies Plc.
  • 12.10. MGI Tech Co., Ltd.

(Note: SWOT analyses of the top 5 companies will be provided.)

13. Appendix

  • 13.1. Available Customization
  • 13.2. Related Reports

LIST OF TABLES

  • Table 1 Global Number of New Cancer Cases, by Type, 2022 Vs. 2040
  • Table 2 Common Genetic Disorders: Rates of Occurrence
  • Table 4 Major Genome Sequencing Projects, by Country
  • Table 5 Health Expenditure, by Country, 2020-2022 (USD)
  • Table 6 Whole Genome Sequencing Kits & Reagents: Pricing
  • Table 7 Whole Genome Sequencing Instruments: Product Description & Pricing
  • Table 9 Ug 100 Specifications
  • Table 10 Aviti Specifications
  • Table 11 Regulatory Authorities Governing In Vitro Diagnostics, by Country/Region
  • Table 12 Global Whole Genome Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 13 Global Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 14 Global Whole Genome Sequencing Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 15 Global Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 16 Global Sample Preparation Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 17 Global Library Preparation & Target Enrichment Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 18 Global Nucleic Acid Extraction & Amplification Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 19 Global Quality Control Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 20 Global Other Kits & Reagents Market, by Country/Region, 2022-2031" (USD Million)
  • Table 21 Global Other Consumables Market, by Country/Region, 2022-2031 (USD Million)
  • Table 22 Some of The Companies offering NGS Instruments for Whole Genome Sequencing are as Follows:
  • Table 23 Global Whole Genome Sequencing Instruments Market, by Country/Region, 2022-2031 (USD Million)
  • Table 24 Key Players offering DNA Sequencing Software
  • Table 25 Global Whole Genome Sequencing Software Market, by Country/Region, 2022-2031 (USD Million)
  • Table 26 Key Players offering Instrument-Related Services
  • Table 27 Global Whole Genome Sequencing Services Market, by Country/Region, 2024-2031 (USD Million)
  • Table 28 Global Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 29 Global Large Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 30 Global Small Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 31 Global Phased Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 32 Global Other Whole Genome Sequencing Types Market, by Country/ Region, 2022-2031 (USD Million)
  • Table 33 Global Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 34 Global Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 35 Global Whole Genome Sequencing Market for Research & Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 36 Global Whole Genome Sequencing Market for Drug Discovery, by Country/Region, 2022-2031 (USD Million)
  • Table 37 Global Whole Genome Sequencing Market for Agriculture & Animal Research, by Country/Region, 2022-2031 (USD Million)
  • Table 38 Global Whole Genome Sequencing Market for Other Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 39 Global Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 40 Global Whole Genome Sequencing Market for Clinical Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 41 Global Whole Genome Sequencing Market for Oncology, by Country/Region, 2022-2031 (USD Million)
  • Table 42 Global Whole Genome Sequencing Market for Reproductive Health, by Country/Region, 2022-2031 (USD Million)
  • Table 43 HIV Prevalence Among Adults, by Region (2020 Vs. 2022) (In Million)
  • Table 44 Global Whole Genome Sequencing Market for Infectious Diseases, by Country/Region, 2022-2031 (USD Million)
  • Table 45 Global Whole Genome Sequencing Market for Other Clinical Applications, by Country/Region, 2022-2031 (USD Million)
  • Table 46 Global Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 47 Global Whole Genome Sequencing Market for Sequencing by Synthesis, by Country/Region, 2022-2031 (USD Million)
  • Table 48 Global Whole Genome Sequencing Market for Ion Semiconductor Sequencing, by Country/Region, 2022-2031 (USD Million)
  • Table 49 Global Whole Genome Sequencing Market for Single-Molecule Real-Time (SMRT) Sequencing, by Country/Region, 2022-2031 (USD Million)
  • Table 50 Global Whole Genome Sequencing Market for DNA Nanoball Sequencing, by Country/Region, 2022-2031 (USD Million)
  • Table 51 Global Whole Genome Sequencing Marker for Other Whole Genome Sequencing Technologies, by Country/Region, 2022-2031 (USD Million)
  • Table 52 Global Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 53 Global Whole Genome Sequencing Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022-2031 (USD Million)
  • Table 54 Global Whole Genome Sequencing Market for Hospitals & Diagnostic Laboratories, by Country/Region, 2022-2031 (USD Million)
  • Table 55 Global Whole Genome Sequencing Market for Academic & Research Institutes, by Country/Region, 2022-2031 (USD Million)
  • Table 56 Global Whole Genome Sequencing Market for Other End Users, by Country/Region, 2022-2031 (USD Million)
  • Table 57 Global Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 58 North America: Whole Genome Sequencing Market, by Country, 2022-2031 (USD Million)
  • Table 59 North America: Whole Genome Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 60 North America: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 61 North America: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 62 North America: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 63 North America: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 64 North America: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 65 North America: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 66 North America: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 67 North America: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 68 U.S.: Key Macroindicators & Microindicators
  • Table 69 U.S.: Whole Genome Sequencing Market, by offering, 2022-2031 (USD Million)
  • Table 70 U.S.: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 71 U.S.: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 72 U.S.: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 73 U.S.: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 74 U.S.: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 75 U.S.: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 76 U.S.: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 77 U.S.: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 78 Some of The Key Active Genomic Projects In Canada, Along With Their Total Investments And Genome Canada Contributions, Are As Follows:
  • Table 79 Canada: Key Macroindicators & Microindicators
  • Table 80 Canada: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 81 Canada: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 82 Canada: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 83 Canada: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 84 Canada: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 85 Canada: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 86 Canada: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 87 Canada: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 88 Canada: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 89 Europe: Whole Genome Sequencing Market, by Country/Region, 2022-2031(USD Million)
  • Table 90 Europe: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 91 Europe: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 92 Europe: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 93 Europe: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 94 Europe: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 95 Europe: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
  • Table 96 Europe: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 97 Europe: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 98 Europe: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 99 Germany: Key Macroindicators & Microindicators
  • Table 100 Germany: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 101 Germany: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 102 Germany: Sample Preparation Consumables Market, by Type, 2022-2031(USD Million)
  • Table 103 Germany: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 104 Germany: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 105 Germany: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
  • Table 106 Germany: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 107 Germany: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 108 Germany: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 109 France: Key Macroindicators & Microindicators
  • Table 110 France: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 111 France: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 112 France: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 113 France: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 114 France: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 115 France: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
  • Table 116 France: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 117 France: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 118 France: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 119 U.K.: Key Macroindicators & Microindicators
  • Table 120 U.K.: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 121 U.K.: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 122 U.K.: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 123 U.K.: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 124 U.K.: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 125 U.K.: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 126 U.K.: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 127 U.K.: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 128 U.K.: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 129 Italy: Key Macroindicators & Microindicators
  • Table 130 Italy: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 131 Italy: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 132 Italy: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 133 Italy: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 134 Italy: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 135 Italy: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 136 Italy: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 137 Italy: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 138 Italy: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 139 Spain: Key Macroindicators & Microindicators
  • Table 140 Spain: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 141 Spain: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 142 Spain: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 143 Spain: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 144 Spain: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 145 Spain: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 146 Spain: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 147 Spain: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 148 Spain: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 149 Number of Sequences in Each Phase And Other Related Sequencing Information In Switzerland
  • Table 150 Roe: Estimated Number of New Cancer Cases, by Country, 2022 Vs. 2030
  • Table 151 Rest of Europe: Whole Genome Sequencing Market, by Offering, 2022-2031(USD Million)
  • Table 152 Rest of Europe: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 153 Rest of Europe: Sample Preparation Consumables Market, by Type, 2022-2031(USD Million)
  • Table 154 Rest of Europe: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 155 Rest of Europe: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 156 Rest of Europe: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
  • Table 157 Rest of Europe: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 158 Rest of Europe: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 159 Rest of Europe: Whole Genome Sequencing Market, by End User, 2022-2031(USD Million)
  • Table 160 Asia-Pacific: Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 161 Asia-Pacific: Whole Genome Sequencing Market, by Offering, 2022-2031(USD Million)
  • Table 162 Asia-Pacific: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 163 Asia-Pacific: Sample Preparation Consumables Market, by Type, 2022-2031(USD Million)
  • Table 164 Asia-Pacific: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 165 Asia-Pacific: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 166 Asia-Pacific: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
  • Table 167 Asia-Pacific: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 168 Asia-Pacific: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 169 Asia-Pacific: Whole Genome Sequencing Market, by End User, 2022-2031(USD Million)
  • Table 170 China: Key Macroindicators & Microindicators
  • Table 171 China: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 172 China: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 173 China: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 174 China: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 175 China: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 176 China: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 177 China: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 178 China: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 179 China: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 180 Japan: Key Macroindicators & Microindicators
  • Table 181 Japan: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 182 Japan: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 183 Japan: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 184 Japan: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 185 Japan: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 186 Japan: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 187 Japan: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 188 Japan: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 189 Japan: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 190 India: Key Macroindicators & Microindicators
  • Table 191 India: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 192 India: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 193 India: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 194 India: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 195 India: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 196 India: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 197 India: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 198 India: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 199 India: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 200 Rest of Asia-Pacific: Estimated Number of New Cancer Cases, by Country, 2022 Vs. 2030
  • Table 201 Projects Funded by Australian Genomics, As Part of Its Genomic Implementation Projects In 2022 And 2023
  • Table 202 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 203 Rest of Asia-Pacific: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 204 Rest of Asia-Pacific: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 205 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 206 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 207 Rest of Asia-Pacific: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 208 Rest of Asia-Pacific: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 209 Rest of Asia-Pacific: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 210 Rest of Asia-Pacific: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 211 Latin America: Whole Genome Sequencing Market, by Country/Region, 2022-2031 (USD Million)
  • Table 212 Latin America: Whole Genome Sequencing Market, by Offering, 2022-2031(USD Million)
  • Table 213 Latin America: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 214 Latin America: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 215 Latin America: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 216 Latin America: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 217 Latin America: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
  • Table 218 Latin America: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 219 Latin America: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 220 Latin America: Whole Genome Sequencing Market, by End User, 2022-2031(USD Million)
  • Table 221 Brazil: Key Macroindicators & Microindicators
  • Table 222 Brazil: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 223 Brazil: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 224 Brazil: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 225 Brazil: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 226 Brazil: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 227 Brazil: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 228 Brazil: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 229 Brazil: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 230 Brazil: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 231 Mexico: Key Macroindicators & Microindicators
  • Table 232 Mexico: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 233 Mexico: Whole Genome Sequencing Consumables Market, by Type, 2022-2031(USD Million)
  • Table 234 Mexico: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 235 Mexico: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031(USD Million)
  • Table 236 Mexico: Whole Genome Sequencing Market, by Technology, 2022-2031(USD Million)
  • Table 237 Mexico: Whole Genome Sequencing Market, by Application, 2022-2031(USD Million)
  • Table 238 Mexico: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 239 Mexico: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 240 Mexico: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 241 Rest of Latin America: Number of New Cancer Cases, by Country, 2022 Vs. 2030
  • Table 242 Rest of Latin America: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 243 Rest of Latin America: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 244 Rest of Latin America: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 245 Rest of Latin America: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 246 Rest of Latin America: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 247 Rest of Latin America: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 248 Rest of Latin America: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 249 Rest of Latin America: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 250 Rest of Latin America: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)
  • Table 251 Middle East & Africa: Whole Genome Sequencing Market, by Offering, 2022-2031 (USD Million)
  • Table 252 Middle East & Africa: Whole Genome Sequencing Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 253 Middle East & Africa: Sample Preparation Consumables Market, by Type, 2022-2031 (USD Million)
  • Table 254 Middle East & Africa: Whole Genome Sequencing Market, by Sequencing Type, 2022-2031 (USD Million)
  • Table 255 Middle East & Africa: Whole Genome Sequencing Market, by Technology, 2022-2031 (USD Million)
  • Table 256 Middle East & Africa: Whole Genome Sequencing Market, by Application, 2022-2031 (USD Million)
  • Table 257 Middle East & Africa: Whole Genome Sequencing Market for Research & Other Applications, by Type, 2022-2031 (USD Million)
  • Table 258 Middle East & Africa: Whole Genome Sequencing Market for Clinical Applications, by Type, 2022-2031 (USD Million)
  • Table 259 Middle East & Africa: Whole Genome Sequencing Market, by End User, 2022-2031 (USD Million)

LIST OF FIGURES

  • Figure 1 Key Stakeholders
  • Figure 2 Research Process
  • Figure 3 Secondary Sources Referenced for This Study
  • Figure 4 Primary Research Techniques
  • Figure 5 Key Executives Interviewed
  • Figure 6 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
  • Figure 7 Market Sizing and Growth forecast Approach
  • Figure 8 Global Whole Genome Sequencing Market, by Offering, 2024 Vs. 2031 (USD Million)
  • Figure 9 Global Whole Genome Sequencing Market, by Sequencing Type, 2024 Vs. 2031 (USD Million)
  • Figure 10 Global Whole Genome Sequencing Market, by Technology, 2024 Vs. 2031 (USD Million)
  • Figure 11 Global Whole Genome Sequencing Market, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 12 Global Whole Genome Sequencing Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 13 Global Whole Genome Sequencing Market, by Geography, 2024 Vs. 2031 (USD Million)
  • Figure 14 Global Whole Genome Sequencing Market: Impact Analysis of Market Drivers, Restraints, Opportunities, And Challenges (2024-2031)
  • Figure 15 Global Share of Cancer Cases, by Region, 2022 Vs. 2040 (%)
  • Figure 16 Pharmaceutical R&D Expenditures in The U.S., Europe, And China, 2010 Vs. 2020 Vs. 2021 (USD Million)
  • Figure 17 Global Pharmaceutical R&D Expenditure, 2014-2028 (USD Billion)
  • Figure 18 Percentage of Approved Personalized Medicines: Cancer Vs. Rare Diseases Vs. Other Diseases, 2022
  • Figure 19 USFDA Regulatory Pathways for IVD Kits
  • Figure 20 Eu Regulatory Pathway - IVDR 2017/746
  • Figure 21 China: Medical Device Classification and Premarket Requirements for IVD Products
  • Figure 22 Porter's Five forces Analysis
  • Figure 23 Global Whole Genome Sequencing Market, by Offering, 2022 Vs. 2031 (USD Million)
  • Figure 24 Steps of Sample Preparation In A Typical Next-Generation Sequencing Workflow
  • Figure 25 Global Whole Genome Sequencing Market, by Sequencing Type, 2024 Vs. 2031 (USD Million)
  • Figure 26 Global Whole Genome Sequencing Market, by Application, 2024 Vs. 2031 (USD Million)
  • Figure 27 U.S.: New Molecular Entity (NME) Approvals
  • Figure 28 Estimated Number of New Cancer Cases (Million)
  • Figure 29 Global Whole Genome Sequencing Market, by Technology, 2024 Vs. 2031 (USD Million)
  • Figure 30 Global Whole Genome Sequencing Market, by End User, 2024 Vs. 2031 (USD Million)
  • Figure 31 Global Pharmaceutical R&D Spending, 2014-2026 (USD Million)
  • Figure 32 Pharmaceutical Spending In 2021 Vs. 2022 (In % of Health Spending)
  • Figure 33 Global Whole Genome Sequencing Market, by Geography, 2024 Vs. 2031 (USD Million)
  • Figure 34 North America: Whole Genome Sequencing Market Snapshot
  • Figure 35 U.S.: Pharmaceutical R&D Expenditure, 2014-2022 (USD Billion)
  • Figure 36 U.S.: Medical and Health R&D Investment Shares, by Source, 2020
  • Figure 37 Research Funding Supported by The Canadian Genomics Enterprise, 2022-2023 (%)
  • Figure 38 Genome Canada Funding Across Sectors, 2022-2023 (USD Million)
  • Figure 39 Europe: Pharmaceutical Industry R&D Expenditure, 2000-2022 (USD Million)
  • Figure 40 Europe: Whole Genome Sequencing Market Snapshot
  • Figure 41 Italy: Number of Biotechnology Firms, 2014-2022
  • Figure 42 Italy: Number of Biotechnology R&D-Dedicated Firms, 2014-2022
  • Figure 43 Rest of Europe: Pharmaceutical R&D Expenditure, 2021 (USD Million)
  • Figure 44 Asia-Pacific: Whole Genome Sequencing Market Snapshot
  • Figure 45 Japan: Pharmaceutical Industry R&D Expenditure, 2014-2022 (USD Million)
  • Figure 46 Japan: Number of New Molecular Entities Approved, 2014-2022
  • Figure 47 Latin America: Whole Genome Sequencing Market Snapshot
  • Figure 48 Key Growth Strategies Adopted by Leading Players, 2021- 2024
  • Figure 49 Global Whole Genome Sequencing Market: Competitive Benchmarking by Offering
  • Figure 50 Global Whole Genome Sequencing Market: Competitive Benchmarking, by Region
  • Figure 51 Competitive Dashboard: Global Whole Genome Sequencing Market
  • Figure 52 Global Whole Genome Sequencing Market Share Analysis, by Key Players, 2023 (%)
  • Figure 53 Illumina, Inc.: Financial Snapshot (2023)
  • Figure 54 Thermo Fisher Scientific Inc.: Financial Snapshot (2023)
  • Figure 55 F. Hoffmann-La Roche Ltd.: Financial Snapshot (2023)
  • Figure 56 QIAGEN N.V: Financial Snapshot (2023)
  • Figure 57 Agilent Technologies, Inc.: Financial Snapshot (2023)
  • Figure 58 Revvity, Inc.: Financial Snapshot (2023)
  • Figure 59 Pacific Biosciences of California Inc.: Financial Snapshot (2023)
  • Figure 60 Danaher Corporation: Financial Snapshot (2023)
  • Figure 61 Oxford Nanopore Technologies Plc.: Financial Snapshot (2023)
  • Figure 62 MGI Tech Co., Ltd.: Financial Snapshot (2023)